{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:21:31Z","timestamp":1786681291112,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022FRNFMT"],"award-info":[{"award-number":["2022FRNFMT"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejpb.2025.114873","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:03:36Z","timestamp":1758585816000},"page":"114873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Structural insights into novel coamorphous systems of azithromycin with faster dissolution profile"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6541-4883","authenticated-orcid":false,"given":"Ilenia","family":"D\u2019Abbrunzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Battaiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-8956","authenticated-orcid":false,"given":"Angela","family":"Abruzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bigucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-9299","authenticated-orcid":false,"given":"Cinzia","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Imbriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2390-7427","authenticated-orcid":false,"given":"Costanza","family":"Fratini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6907-8904","authenticated-orcid":false,"given":"Luca","family":"Casettari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3830-8038","authenticated-orcid":false,"given":"Dario","family":"Voinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-9121","authenticated-orcid":false,"given":"Dritan","family":"Hasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114873_b0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/ph17020187","article-title":"Hybrid Molecules of Azithromycin with Chloramphenicol and Metronidazole: Synthesis and Study of Antibacterial Properties","volume":"17","author":"Volynkina","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2025.114873_b0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1068-607X(02)00112-9","article-title":"Azithromycin\u2014a new macrolide","volume":"9","author":"Kremer","year":"2002","journal-title":"Prim Care Update Ob Gyns"},{"key":"10.1016\/j.ejpb.2025.114873_b0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","article-title":"Mercury 4.0: from visualization to analysis, design and prediction","volume":"53","author":"MacRae","year":"2020","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejpb.2025.114873_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2019.112398","article-title":"Solubility determination and correlation for azithromycin monohydrate and dihydrate in solvent mixtures","volume":"301","author":"Cao","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2025.114873_b0025","first-page":"31","article-title":"The new macrolides. Azithromycin and clarithromycin","volume":"160","author":"Kanatani","year":"1994","journal-title":"West. J. Med."},{"key":"10.1016\/j.ejpb.2025.114873_b0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3109\/03639045.2013.850713","article-title":"Pediatric drug development: formulation considerations","volume":"40","author":"Ali","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0035","doi-asserted-by":"crossref","unstructured":"P.P. Srinivas, N. Prabhu, V. SG, N. Patel, A. Pai, V. Pai, M. Badamane Sathyanarayana, Designing of stable co-crystals of azithromycin using suitable coformers, RASAYAN J Chem 15 (2022) 2417\u20132428. 10.31788\/RJC.2022.1546985.","DOI":"10.31788\/RJC.2022.1546985"},{"key":"10.1016\/j.ejpb.2025.114873_b0040","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/antibiotics10080939","article-title":"Enhancing Dissolution Rate and Antibacterial Efficiency of Azithromycin through Drug-Drug Cocrystals with Paracetamol","volume":"10","author":"Ul Islam","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejpb.2025.114873_b0045","unstructured":"K.P. Upadhye, C.S. Dhakate, G.R. Dixit, S.S. Bakhle, Development and Evaluation of Taste Masked Azithromycin by Crystal Engineering, Int J Drug Deliv Technol 11 (2021) 920\u2013925. 10.25258\/ijddt.11.3.46."},{"key":"10.1016\/j.ejpb.2025.114873_b0050","unstructured":"CN100427499C - Soluble salt of azithromycin and its preparation process - Google Patents, https:\/\/patents.google.com\/patent\/CN100427499C\/en (accessed March 25, 2025)."},{"key":"10.1016\/j.ejpb.2025.114873_b0055","unstructured":"WO2004106355A1 - Addition salts of azithromycin and citric acid and process for preparing them - Google Patents, https:\/\/patents.google.com\/patent\/WO2004106355A1\/en (accessed March 25, 2025)."},{"key":"10.1016\/j.ejpb.2025.114873_b0060","first-page":"1","article-title":"Preparation and evaluation of azithromycin binary solid dispersions using various polyethylene glycols for the improvement of the drug solubility and dissolution rate, Brazilian","volume":"52","author":"Adeli","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/2231-4040.72262","article-title":"Development, characterization and solubility study of solid dispersions of azithromycin dihydrate by solvent evaporation method","volume":"1","author":"Arora","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ejpb.2025.114873_b0070","article-title":"Solubility Enhancment of Azithromycin by Solid Dispersion Method by using Polymer PVP K 90","volume":"121\u2013124","author":"Zinjad","year":"2019","journal-title":"J Drug Deliv Therap 9"},{"key":"10.1016\/j.ejpb.2025.114873_b0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/polym14030495","article-title":"Preparation of Azithromycin Amorphous Solid Dispersion by Hot-Melt Extrusion: an Advantageous Technology with taste Masking and Solubilization Effects","volume":"14","author":"Li","year":"2022","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.ejpb.2025.114873_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12247-019-09422-3","article-title":"Formulation and Evaluation of Cyclodextrin-based Thermosensitive In Situ Gel of Azithromycin for Periodontal delivery","volume":"16","author":"Raval","year":"2021","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejpb.2025.114873_b0085","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/pharmaceutics14071389","article-title":"Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-delivery Systems\u2014A Pharmaceutical Perspective","volume":"14","author":"Boczar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114873_b0090","first-page":"425","article-title":"Effect of Surfactant on Azithromycin Dihydrate Loaded Stearic Acid Solid Lipid Nanoparticles., Turk","volume":"16","author":"Bhattacharyya","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0095","first-page":"2917","article-title":"Preparation and Characterization of Azithromycin-Loaded Nanostructured Lipid Carriers","volume":"236\u2013238","author":"Wu","year":"2011","journal-title":"Adv. Mat. Res."},{"key":"10.1016\/j.ejpb.2025.114873_b0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jac\/dku452","article-title":"Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients","volume":"70","author":"Solleti","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2025.114873_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121782","article-title":"Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection","author":"Baz\u00e1n Henostroza","year":"2022","journal-title":"Int J Pharm 621"},{"key":"10.1016\/j.ejpb.2025.114873_b0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1107\/S2052520616003954","article-title":"The Cambridge Structural Database","volume":"72","author":"Groom","year":"2016","journal-title":"Acta Crystallogr B Struct Sci Cryst Eng Mater"},{"key":"10.1016\/j.ejpb.2025.114873_b0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2008.06.022","article-title":"Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation","volume":"71","author":"Chieng","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122840","article-title":"Co-amorphous systems consisting of indomethacin and the chiral co-former tryptophan: Solid-state properties and molecular mobilities","volume":"636","author":"Holzapfel","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijpharm.2018.12.036","article-title":"Co-former selection for co-amorphous drug-amino acid formulations","volume":"557","author":"Kasten","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2015.12.009","article-title":"Recent advances in co-amorphous drug formulations","volume":"100","author":"Dengale","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114873_b0135","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/acs.molpharmaceut.8b01229","article-title":"Transformations between Co-Amorphous and Co-Crystal Systems and their Influence on the Formation and Physical Stability of Co-Amorphous Systems","volume":"16","author":"Wu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2012.04.066","article-title":"Emerging trends in the stabilization of amorphous drugs","volume":"453","author":"Laitinen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0145","first-page":"389","article-title":"Co-Amorphous Drug Formulations in Numbers: recent advances in Co-Amorphous Drug Formulations with Focus on Co-Formability","volume":"13","author":"Liu","year":"2021","journal-title":"Molar Ratio, Preparation Methods, Physical Stability, in Vitro and in Vivo Performance, and New Formulation Strategies, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114873_b0150","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/acs.molpharmaceut.2c00873","article-title":"Influence of Co-amorphization on the Physical Stability and Dissolution Performance of an Anthelmintic Drug Flubendazole","volume":"20","author":"Vasilev","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/pharmaceutics17010092","article-title":"Stability of Ternary Drug\u2013Drug\u2013Drug Coamorphous Systems Obtained through Mechanochemistry","volume":"17","author":"D\u2019Abbrunzo","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114873_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121475","article-title":"Design and molecular insights of drug-active metabolite based co-amorphous formulation: a case study of toltrazuril-ponazuril co-amorphous","volume":"615","author":"Li","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.xphs.2024.08.029","article-title":"Amorphous solubility advantage: Theoretical considerations, experimental methods, and contemporary relevance","volume":"114","author":"Ueda","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejpb.2011.10.006","article-title":"Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin","volume":"80","author":"Karmwar","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0175","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jps.23031","article-title":"Assessing the performance of amorphous solid dispersions","volume":"101","author":"Newman","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0180","doi-asserted-by":"crossref","unstructured":"R. Laitinen, P.A. Priemel, S. Surwase, K. Graeser, C.J. Strachan, H. Grohganz, T. Rades, Theoretical Considerations in Developing Amorphous Solid Dispersions, Advances in Delivery Science and Technology in: Springer (New York) (2014) 35\u201390. 10.1007\/978-1-4939-1598-9_2.","DOI":"10.1007\/978-1-4939-1598-9_2"},{"key":"10.1016\/j.ejpb.2025.114873_b0185","first-page":"2887","article-title":"Enhancement of the Physical Stability of Amorphous Indomethacin by Mixing it with Octaacetylmaltose","volume":"31","author":"Kaminska","year":"2014","journal-title":"Inter and Intra Molecular Studies, Pharm Res"},{"key":"10.1016\/j.ejpb.2025.114873_b0190","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2023.01.019","article-title":"Mechanistic insights into the crystallization of coamorphous drug systems","volume":"354","author":"Heng","year":"2023","journal-title":"JCR"},{"key":"10.1016\/j.ejpb.2025.114873_b0195","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/acs.molpharmaceut.2c00307","article-title":"Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations","volume":"19","author":"Li","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0200","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/cg200492w","article-title":"Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals","volume":"11","author":"Babu","year":"2011","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2025.114873_b0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.apsb.2018.08.002","article-title":"Advances in coamorphous drug delivery systems","volume":"9","author":"Shi","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2025.114873_b0210","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/pharmaceutics15061574","article-title":"Preparation of Co-Amorphous Levofloxacin Systems for Pulmonary Application","volume":"15","author":"Gabelmann","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114873_b0215","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.xphs.2021.02.005","article-title":"Coamorphous System of Florfenicol-Oxymatrine for improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics simulation","volume":"110","author":"Li","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0220","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/acs.molpharmaceut.3c00947","article-title":"Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: an Experimental\u2013Theoretical Study","volume":"21","author":"Queiroz","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2022.09.002","article-title":"Platensimycin-berberine chloride co-amorphous drug system: Sustained release and prolonged half-life","volume":"179","author":"Wang","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0230","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1039\/B815174A","article-title":"The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome","volume":"11","author":"Fri\u0161\u010di\u0107","year":"2009","journal-title":"CrstEngComm"},{"key":"10.1016\/j.ejpb.2025.114873_b0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.xphs.2016.06.017","article-title":"Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib","volume":"106","author":"Xie","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0240","unstructured":"European Synchrotron Radiation Facility (ESRF), https:\/\/www.esrf.fr\/ (accessed November 23, 2024)."},{"key":"10.1016\/j.ejpb.2025.114873_b0245","unstructured":"Fast Azimuthal Integration using Python \u2014 pyFAI 2024.9.0 documentation, https:\/\/pyfai.readthedocs.io\/en\/stable\/ (accessed November 23, 2024)."},{"key":"10.1016\/j.ejpb.2025.114873_b0250","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/antibiotics11081040","article-title":"Development and Characterization of Azithromycin-Loaded Microemulsions: a Promising Tool for the Treatment of Bacterial Skin Infections","volume":"11","author":"Abruzzo","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejpb.2025.114873_b0255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/pr7050276","article-title":"Hollow and Solid Spherical Azithromycin Particles Prepared by Different Spherical Crystallization Technologies for Direct Tableting","volume":"7","author":"Chen","year":"2019","journal-title":"Processes"},{"key":"10.1016\/j.ejpb.2025.114873_b0260","unstructured":"Ethyl Acetate | CH3COOC2H5 | CID 8857 - PubChem, https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/8857 (accessed November 23, 2024)."},{"key":"10.1016\/j.ejpb.2025.114873_b0265","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3390\/ma4091564","article-title":"On Structure and Properties of Amorphous Materials","volume":"4","author":"Stachurski","year":"2011","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2025.114873_b0270","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/pharmaceutics13081253","article-title":"Structure and Glass transition Temperature of Amorphous Dispersions of Model Pharmaceuticals with Nucleobases from Molecular Dynamics","volume":"13","author":"\u010cervinka","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114873_b0275","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","article-title":"Pharmaceutical applications of Solid Dispersion Systems","volume":"60","author":"Chiou","year":"1971","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0280","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1023\/A:1016292416526","article-title":"Molecular Mobility of Amorphous Pharmaceutical Solids Below their Glass transition Temperatures","volume":"12","author":"Hancock","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114873_b0285","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1023\/A:1011983606606","article-title":"Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid and PVP","volume":"15","author":"Lu","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114873_b0290","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0006-3495(00)76365-X","article-title":"High critical Temperature above Tg May Contribute to the Stability of Biological Systems","volume":"79","author":"Buitink","year":"2000","journal-title":"Biophys. J ."},{"key":"10.1016\/j.ejpb.2025.114873_b0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2008.10.011","article-title":"Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling","volume":"367","author":"Feng","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0300","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2015.08.101","article-title":"Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability","volume":"495","author":"Alhalaweh","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114873_b0305","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.ddtec.2011.10.002","article-title":"The use of amorphous solid dispersions: a formulation strategy to overcome poor solubility and dissolution rate","volume":"9","author":"Van den Mooter","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejpb.2025.114873_b0310","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/jps.2600831211","article-title":"Crystallization of Indomethacin from the Amorphous State below and above its Glass transition Temperature","volume":"83","author":"Yoshioka","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0315","unstructured":"S.J.L. Billinge, Total scattering and atomic pair distribution function analysis: overview and applications. https:\/\/www.bnl.gov\/pdfschool2018\/files\/2018-talks\/billinge.pdf (accessed November 23, 2024)."},{"key":"10.1016\/j.ejpb.2025.114873_b0320","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/acs.chemrev.1c00237","article-title":"Structural Analysis of Molecular Materials using the Pair distribution Function","volume":"122","author":"Terban","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2025.114873_b0325","article-title":"The rise of the X-ray atomic pair distribution function method: a series of fortunate events","volume":"377","author":"Billinge","year":"2019","journal-title":"Philos. Transact. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.ejpb.2025.114873_b0330","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1524\/zkri.218.2.132.20664","article-title":"Structural analysis of complex materials using the atomic pair distribution function \u2014 a practical guide","volume":"218","author":"Proffen","year":"2003","journal-title":"Z Kristallogr Cryst Mater"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:39:59Z","timestamp":1773128399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125002504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":66,"alternative-id":["S0939641125002504"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114873","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural insights into novel coamorphous systems of azithromycin with faster dissolution profile","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114873"}}